相似文献
1
Estrogen and ERalpha: culprits in cervical cancer?
Trends Endocrinol Metab. 2010 Aug;21(8):504-11. doi: 10.1016/j.tem.2010.03.005. Epub 2010 Apr 22.
2
Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19467-72. doi: 10.1073/pnas.0911436106. Epub 2009 Nov 9.
3
ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
Virus Res. 2021 Dec;306:198602. doi: 10.1016/j.virusres.2021.198602. Epub 2021 Oct 15.
4
Requirement for stromal estrogen receptor alpha in cervical neoplasia.
Horm Cancer. 2013 Feb;4(1):50-9. doi: 10.1007/s12672-012-0125-7. Epub 2012 Oct 13.
5
Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Cancer Res. 2008 Dec 1;68(23):9928-34. doi: 10.1158/0008-5472.CAN-08-2051.
6
Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.
Carcinogenesis. 2014 Feb;35(2):489-96. doi: 10.1093/carcin/bgt350. Epub 2013 Oct 22.
7
Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy.
Am J Pathol. 2014 Feb;184(2):530-40. doi: 10.1016/j.ajpath.2013.10.013.
8
Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer.
Anticancer Res. 1999 May-Jun;19(3A):1673-80.
9
Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
Cancer Res. 2009 Apr 15;69(8):3300-7. doi: 10.1158/0008-5472.CAN-08-2036. Epub 2009 Apr 7.
10
Functional roles of female sex hormones and their nuclear receptors in cervical cancer.
Essays Biochem. 2021 Dec 17;65(6):941-950. doi: 10.1042/EBC20200175.
引用本文的文献
1
A correlation study between cervical cancer and sex hormones.
Front Oncol. 2024 Nov 29;14:1475052. doi: 10.3389/fonc.2024.1475052. eCollection 2024.
2
A Random Survival Forest Model for Predicting Residual and Recurrent High-Grade Cervical Intraepithelial Neoplasia in Premenopausal Women.
Int J Womens Health. 2024 Oct 30;16:1775-1787. doi: 10.2147/IJWH.S485515. eCollection 2024.
3
The role of epigenetics in women's reproductive health: the impact of environmental factors.
Front Endocrinol (Lausanne). 2024 Sep 13;15:1399757. doi: 10.3389/fendo.2024.1399757. eCollection 2024.
4
Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses.
J Virol. 2024 Oct 22;98(10):e0102424. doi: 10.1128/jvi.01024-24. Epub 2024 Sep 13.
5
The Impact of Tamoxifen Usage in Breast Cancer Patients on the Development of Histopathological Lesions in the Cervix Uteri.
Medicina (Kaunas). 2024 Aug 6;60(8):1268. doi: 10.3390/medicina60081268.
6
The protective effect of vinpocetine against Estradiol-benzoate induced cervical hyperkeratosis in female rats via modulation of SIRT1/Nrf2, and NLRP3 inflammasome.
Sci Rep. 2024 Aug 19;14(1):19171. doi: 10.1038/s41598-024-69431-2.
7
Association between dyslipidemia and cervical intraepithelial neoplasia: A case-control study in south-western Uganda.
Afr J Lab Med. 2024 Jul 16;13(1):2374. doi: 10.4102/ajlm.v13i1.2374. eCollection 2024.
8
Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional study.
Int J Surg. 2025 Jan 1;111(1):891-903. doi: 10.1097/JS9.0000000000001956.
9
The prognostic value of MEK pathway-associated estrogen receptor signaling activity for female cancers.
Br J Cancer. 2024 May;130(11):1875-1884. doi: 10.1038/s41416-024-02668-w. Epub 2024 Apr 6.
10
High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer.
Cell Commun Signal. 2024 Mar 28;22(1):198. doi: 10.1186/s12964-024-01582-1.
本文引用的文献
1
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen.
J Clin Oncol. 2010 Jan 20;28(3):509-18. doi: 10.1200/JCO.2009.23.1274. Epub 2009 Nov 30.
2
Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19467-72. doi: 10.1073/pnas.0911436106. Epub 2009 Nov 9.
3
Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2957-64. doi: 10.1158/1055-9965.EPI-09-0698. Epub 2009 Oct 27.
4
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
BMJ. 2009 Jul 28;339:b2569. doi: 10.1136/bmj.b2569.
5
Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
Cancer Res. 2009 Jul 15;69(14):5656-63. doi: 10.1158/0008-5472.CAN-08-3711. Epub 2009 Jul 7.
6
Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Cancer Res. 2009 May 15;69(10):4407-14. doi: 10.1158/0008-5472.CAN-09-0023. Epub 2009 May 12.
7
Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
Cancer Res. 2009 Apr 15;69(8):3300-7. doi: 10.1158/0008-5472.CAN-08-2036. Epub 2009 Apr 7.
8
Papillomaviruses in the causation of human cancers - a brief historical account.
Virology. 2009 Feb 20;384(2):260-5. doi: 10.1016/j.virol.2008.11.046. Epub 2009 Jan 8.
9
Papillomavirus E6 proteins.
Virology. 2009 Feb 20;384(2):324-34. doi: 10.1016/j.virol.2008.11.017. Epub 2008 Dec 10.
10
Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Cancer Res. 2008 Dec 1;68(23):9928-34. doi: 10.1158/0008-5472.CAN-08-2051.
Zotero 插件